JP2009500310A5 - - Google Patents

Download PDF

Info

Publication number
JP2009500310A5
JP2009500310A5 JP2008518835A JP2008518835A JP2009500310A5 JP 2009500310 A5 JP2009500310 A5 JP 2009500310A5 JP 2008518835 A JP2008518835 A JP 2008518835A JP 2008518835 A JP2008518835 A JP 2008518835A JP 2009500310 A5 JP2009500310 A5 JP 2009500310A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutical composition
composition according
general formula
alkylene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008518835A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009500310A (ja
Filing date
Publication date
Priority claimed from DE102005030733A external-priority patent/DE102005030733A1/de
Application filed filed Critical
Publication of JP2009500310A publication Critical patent/JP2009500310A/ja
Publication of JP2009500310A5 publication Critical patent/JP2009500310A5/ja
Pending legal-status Critical Current

Links

JP2008518835A 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも１種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物 Pending JP2009500310A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102005030733A DE102005030733A1 (de) 2005-07-01 2005-07-01 Neue Arzneimittelkombinationen zur Behandlung von Atemwegserkrankungen enthaltend langwirksame Beta-2-Agonisten und wenigstens einen weiteren Wirkstoff
PCT/EP2006/063650 WO2007003554A1 (de) 2005-07-01 2006-06-28 Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen enthaltend langwirksame beta-2-agonisten und wenigstens einen weiteren wirkstoff

Publications (2)

Publication Number Publication Date
JP2009500310A JP2009500310A (ja) 2009-01-08
JP2009500310A5 true JP2009500310A5 (https=) 2009-08-13

Family

ID=37087177

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008518835A Pending JP2009500310A (ja) 2005-07-01 2006-06-28 長時間作用性のベータ作用薬と少なくとも１種の更なる有効成分とを含む呼吸器系疾患治療用の新規な医薬組成物

Country Status (9)

Country Link
US (1) US20070037781A1 (https=)
EP (1) EP1901776B1 (https=)
JP (1) JP2009500310A (https=)
AR (1) AR054810A1 (https=)
AT (1) ATE546159T1 (https=)
CA (1) CA2613828A1 (https=)
DE (1) DE102005030733A1 (https=)
TW (1) TW200740440A (https=)
WO (1) WO2007003554A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060035893A1 (en) * 2004-08-07 2006-02-16 Boehringer Ingelheim International Gmbh Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
US8507502B2 (en) * 2008-11-10 2013-08-13 National Health Research Institutes Fused bicyclic and tricyclic pyrimidine compounds as tyrosine kinase inhibitors
CN103874696B (zh) * 2011-10-12 2015-06-03 苏州韬略生物科技有限公司 作为激酶抑制剂的喹唑啉衍生物及其使用方法
JP6469727B2 (ja) * 2014-06-02 2019-02-13 メディシノバ・インコーポレイテッドＭｅｄｉｃｉＮｏｖａ， Ｉｎｃ． 線維症の抑制又は治療方法
SG11201806166WA (en) * 2016-02-08 2018-08-30 Redx Pharma Plc Heterocyclic compounds, in particular 2-oxo-4,4,5,5,6,6,7,7-octahydrobenzoxazole derivatives, and their use as antibacterial compounds
EP3488851A1 (en) * 2018-10-03 2019-05-29 AVM Biotechnology, LLC Immunoablative therapies

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2609645A1 (de) * 1976-03-09 1977-09-15 Boehringer Sohn Ingelheim Aminoalkylheterocyclen
US4570630A (en) * 1983-08-03 1986-02-18 Miles Laboratories, Inc. Medicament inhalation device
AU591152B2 (en) 1985-07-30 1989-11-30 Glaxo Group Limited Devices for administering medicaments to patients
SE453566B (sv) 1986-03-07 1988-02-15 Draco Ab Anordning vid pulverinhalatorer
SG45171A1 (en) 1990-03-21 1998-01-16 Boehringer Ingelheim Int Atomising devices and methods
DE4318455A1 (de) 1993-06-03 1994-12-08 Boehringer Ingelheim Kg Kapselhalterung
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
BR9913152A (pt) * 1998-08-26 2001-05-15 Smithkline Beecham Corp Terapias para tratamento de doenças pulmonares
WO2002030928A1 (de) 2000-10-12 2002-04-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Kristallines monohydrat, verfahren zu dessen herstellung und dessen verwendung zur herstellung eines arzneimittels
DE10050995A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
ME00412B (me) 2001-06-22 2011-10-10 Boehringer Ingelheim Pharma Kristalni antiholinergik , postupak za njegovo pripremanje i njegova primjena u proizvodnji lijeka
DE10203741A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Fluorencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203753A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Xanthencarbonsäureester, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10203749A1 (de) 2002-01-31 2003-08-14 Boehringer Ingelheim Pharma Neue Anticholinergika, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
DE10246374A1 (de) * 2002-10-04 2004-04-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Betamimetika mit verlängerter Wirkungsdauer, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
DE10253282A1 (de) * 2002-11-15 2004-05-27 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Arzneimittel zur Behandlung von chronisch obstruktiver Lungenerkrankung
US7056916B2 (en) * 2002-11-15 2006-06-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Medicaments for the treatment of chronic obstructive pulmonary disease
DK1567139T3 (da) * 2002-11-27 2008-11-03 Nycomed Gmbh Hidtil ukendt synergistisk kombination der omfatter roflumilast og formoterol
JP2007500676A (ja) * 2003-07-31 2007-01-18 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 抗コリン作用薬とベータ受容体刺激薬を含む吸入用薬剤
EP1654001A2 (en) * 2003-08-05 2006-05-10 Boehringer Ingelheim International GmbH Medicaments for inhalation comprising steroids and a betamimetic
DE102004003428A1 (de) * 2004-01-23 2005-08-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue langwirksame Beta-2-Agonisten, und deren Verwendung als Arzneimittel

Similar Documents

Publication Publication Date Title
JP2007533683A5 (https=)
ES2399179T3 (es) Tratamiento de enfermedad respiratoria
JP2007518738A5 (https=)
JP2005524664A (ja) β２−アゴニストの溶液を含有する加圧式定量用量吸入器
CA2427282A1 (en) Mixtures or organic compounds for the treatment of airway diseases
JP2008500988A5 (https=)
JP2004521134A5 (https=)
KR101344225B1 (ko) 호흡기 장애의 치료를 위한 신규한 약제학적 병용제제
JP2007517067A5 (https=)
KR20140012989A (ko) 글리코피롤레이트 및 베타2-효능제의 조합
JP2007500676A5 (https=)
JP2009513516A (ja) 抗コリン作用薬を含むｈｆｃ溶液製剤
JP2015520738A5 (https=)
JP2009500310A5 (https=)
JP2016532677A5 (https=)
JP2019501876A5 (https=)
CA2481268A1 (en) Medicaments comprising steroids and a novel anticholinergic
JP2017522348A5 (https=)
JP2007522141A5 (https=)
US9682038B2 (en) Pharmaceutical compositions comprising multi-component crystalline particles suitable for use in inhalation therapy
TWI296934B (en) Inhalable formulation of a solution containing a tiotropium salt
JP2023540171A5 (https=)
CA2534128A1 (en) Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation
JP2009537585A (ja) 呼吸器疾患の治療のための新規医薬組成物
JP5259193B2 (ja) 加圧下にある用量計量型吸入器用の金属イオン封鎖剤を含む薬用エーロゾル配合物